0001517941-19-000001.txt : 20190314 0001517941-19-000001.hdr.sgml : 20190314 20190314142015 ACCESSION NUMBER: 0001517941-19-000001 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190314 DATE AS OF CHANGE: 20190314 EFFECTIVENESS DATE: 20190314 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Carmell Therapeutics Corp CENTRAL INDEX KEY: 0001517941 IRS NUMBER: 263671988 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-316859 FILM NUMBER: 19680692 BUSINESS ADDRESS: STREET 1: 10 SOUTH TOWER STREET 2: 320 E. NORTH AVENUE CITY: PITTSBURGH STATE: PA ZIP: 15212 BUSINESS PHONE: (412) 508-6519 MAIL ADDRESS: STREET 1: 10 SOUTH TOWER STREET 2: 320 E. NORTH AVENUE CITY: PITTSBURGH STATE: PA ZIP: 15212 D/A 1 primary_doc.xml X0708 D/A LIVE 0001517941 Carmell Therapeutics Corp 2403 Sidney Street, Suite 300 PITTSBURGH PA PENNSYLVANIA 15203 215-688-6196 DELAWARE CarMell, LLC None Corporation true Randolph Hubbell c/o Carmell Therapeutics Corporation 2403 Sidney Street, Suite 300 Pittsburgh PA PENNSYLVANIA 15203 Executive Officer Director James Hart c/o Carmell Therapeutics Corporation 2403 Sidney Street, Suite 300 Pittsburgh PA PENNSYLVANIA 15203 Executive Officer Donna Godward c/o Carmell Therapeutics Corporation 2403 Sidney Street, Suite 300 Pittsburgh PA PENNSYLVANIA 15203 Executive Officer Richard Upton c/o Carmell Therapeutics Corporation 2403 Sidney Street, Suite 300 Pittsburgh PA PENNSYLVANIA 15203 Director James F. Jordan c/o Carmell Therapeutics Corporation 2403 Sidney Street, Suite 300 Pittsburgh PA PENNSYLVANIA 15203 Director David W. Anderson c/o Carmell Therapeutics Corporation 2403 Sidney Street, Suite 300 Pittsburgh PA PENNSYLVANIA 15203 Director Stephanie Kladakis c/o Carmell Therapeutics Corporation 2403 Sidney Street, Suite 300 Pittsburgh PA PENNSYLVANIA 15203 Executive Officer Wendy DiCicco c/o Carmell Therapeutics Corporation 2403 Sidney Street, Suite 300 Pittsburgh PA PENNSYLVANIA 15203 Director Biotechnology Decline to Disclose 06b true 0001517941-18-000003 2018-07-09 false true true false 0 Dalmore Group, LLC 136352 None None 525 Green Place Woodmere NY NEW YORK 11598 AL ALABAMA AK ALASKA AZ ARIZONA AR ARKANSAS CA CALIFORNIA CO COLORADO CT CONNECTICUT DE DELAWARE DC DISTRICT OF COLUMBIA FL FLORIDA GA GEORGIA ID IDAHO IL ILLINOIS IN INDIANA IA IOWA KS KANSAS KY KENTUCKY LA LOUISIANA ME MAINE MD MARYLAND MA MASSACHUSETTS MI MICHIGAN MN MINNESOTA MS MISSISSIPPI MO MISSOURI MT MONTANA NE NEBRASKA NV NEVADA NH NEW HAMPSHIRE NJ NEW JERSEY NM NEW MEXICO NY NEW YORK NC NORTH CAROLINA ND NORTH DAKOTA OH OHIO OK OKLAHOMA OR OREGON PA PENNSYLVANIA RI RHODE ISLAND SC SOUTH CAROLINA SD SOUTH DAKOTA TN TENNESSEE TX TEXAS UT UTAH VT VERMONT VA VIRGINIA WA WASHINGTON WV WEST VIRGINIA WI WISCONSIN WY WYOMING false 7500000 5184535 2315465 false 44 855000 true 0 Represents up to 9% placement agent fee. 0 false Carmell Therapeutics Corp /s/ Randolph W. Hubbell Randolph W. Hubbell Chief Executive Officer and President 2019-03-14